Tagged Articles

Meridia 21 articles

Love my Body diet pills recalled, contain dangerous drug ingredients

Love my Tru Body based in McDonough, Ga., is recalling all Skinny Bee Diet 500mg capsules after laboratory testing found undeclared drug ingredients that are both dangerous and illegal in the U.S. The Food and Drug Administration (FDA) said that the diet pills contained sibutramine, desmethylsibutramine, and phenolphthalein. Sibutramine is an appetite suppressant that was the active ingredient in the prescription obesity treatment Meridia. The drug was pulled from the market in 2010 after it was linked to dangerous increases in blood pressure and pulse rate that could pose a significant health risk to patients with a history of coronary artery disease, ... Read More

Lucy’s Weight Loss System slapped with FDA warning letter for tainted diet pills

Lucy’s Weight Loss System of Arlington, Texas, has been slapped with a warning letter by the Food and Drug Administration (FDA) for not adequately initiating a recall of its dietary supplements after an inspection revealed the products contained undeclared drug ingredients that could be harmful to consumers. The FDA confirmed through laboratory analysis that Pink Bikini (White Capsules), Pink Bikini (Blue Capsules), Shorts on the Beach (Blue Capsules) and Shorts on the Beach (Golden Edition) contained sibutramine, phenolphthalein and/or diclofenac. Sibutramine is an appetite suppressant that was sold under the brand name Meridia and pulled from the U.S. market in ... Read More

Tainted dietary supplements seized by federal agents

Tainted dietary supplements made by Globe All Wellness (Globe All), in Hollywood, Fla., were seized by U.S. Marshals acting on behalf of the Food and Drug Administration (FDA) because the products contain an undisclosed active pharmaceutical ingredient and may be unsafe. Several of the seized products contain sibutramine hydrochloride (sibutramine), the active ingredient in the obesity drug Merida. In December 2010, the FDA pulled Meridia from the U.S. market after clinical data showed the drug increased the risk for heart attacks and strokes. Globe All claims its products can lower blood pressure and cholesterol, as well as improve other health ... Read More

New diet drug Qsymia now available by prescription

The much anticipated diet drug Qsymia is officially on the market. Qsymia, made by Vivus, is one of two new weight loss drugs approved earlier this year by the Food and Drug Administration (FDA), becoming the first diet pills cleared by the FDA in more than 13 years. Unlike other drugs for weight loss, Qsymia, and new rival Belviq, are considered “life-long” treatments for obesity and should be used along with a diet and exercise program. Though both help users lose weight, they work in entirely different ways. Belviq contains the active ingredient lorcaserin, which works by activating a part ... Read More

FDA approves two life-long prescription diet drugs

Two new medications are the first in 13 years to be approved by the Food and Drug Administration (FDA) for long-term weight management. Marketed as Belviq and Qsymia, the prescription drugs are designed to be taken for the rest of a person’s life – along with a healthy lifestyle – for obese and overweight people who have been unsuccessful in getting their weight under control with diet and exercise. More than a third of adults in the United States are obese, and obesity contributes to a number of health conditions including high blood pressure, type 2 diabetes, and high cholesterol. “For ... Read More

FDA approves Belviq, first weight loss drug in more than a decade

A new prescription weight-loss pill has been approved by the Food and Drug Administration (FDA), making it the first diet pill to hit the U.S. market in more than a decade. Arena Pharmaceuticals Belviq (lorcasserin) was deemed safe enough to get a nod by drug regulators, though the agency says studies showed only modest weight loss in clinical trials. Belviq was approved for adults who are obese or overweight with at least one medical complication such as diabetes or high cholesterol. The drug should be used with a healthy diet and exercise. The FDA first rejected Belviq in 2010 after ... Read More

FDA delays vote on experimental diet drug Qnexa

Approval for the experimental weight loss drug Qnexa has been pushed back another three months, paving the way for other drugs to stretch ahead in the race for the first diet pill in 13 years to be granted marketing rights in the United States. The Food and Drug Administration (FDA) pushed back the target date for approval to allow time to review a new safety plan submitted by drug maker Vivus Inc. These plans often include information that explains side effects and safety risks. Side effects reported with Qnexa include birth defects, heart palpitations, suicidal thoughts, and memory lapses. Vivus ... Read More

FDA advises diet drug makers to assess heart risks

Pharmaceutical companies who develop weight loss drugs need to study their medications to determine heart risks before seeking approval from health regulators, the Food and Drug Administration (FDA) said in a report released this week. Three drug companies are vying to get approval for what would be the first diet pills to hit the market in 13 years. Vivus’s drug Qnexa will be reviewed by an FDA panel in April, and Arena’s medication lorcasserin will be reviewed in May. Drug company Orexigen agreed in September to conduct safety studies on its diet pill, Contrave. Contrave hit a snag with FDA ... Read More

Diet pill indicated as contributing cause of Bubba Smith’s death

Results from an autopsy indicate the diet pill phentermine contributed to the death of Bubba Smith, the towering all-pro football player-turned-actor and commercial spokesman. Smith was also found to have heart disease and high blood pressure. He was 66. The autopsy report listed as a contributing cause of death acute phentermine intoxication, a condition that can cause the heart to beat irregularly and the body to overheat until the person collapses. Phentermine was one ingredient in the diet pill combination “Fen-Phen,” which was pulled from the market after it was shown to cause serious heart risks. Fenfluramine – the “fen” ... Read More

FDA to consider diet pill with birth defects warning

California-based drug company Vivus Inc. is hoping to win Food and Drug Administration (FDA) approval for its experimental diet drug Qnexa, after it was rejected last October because of concerns that it may cause birth defects and increased heart rate. Vivus has resubmitted Qnexa as a treatment for obese or overweight patients with weight-related disorders such as high blood pressure or diabetes with a new warning that the drug should not be used by women of childbearing age. In addition to the new warning label, the resubmission also includes a risk evaluation and mitigation strategy. An FDA advisory panel is ... Read More